P

PharmaEssentia

204 employees

PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis, and other diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Orphan Disease
Biotechnology
Health Care
Hematology
Biologics
Oncology
Pharmaceutical
Drug Development
Orphan Drugs
Pharmaceuticals
Rare Disease

Date founded

2003

Funding rounds raised

P

PharmaEssentia raised undisclosed on August 15, 2022

Investors: Taiwania Capital

FAQ